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Ocular  enucleation  induces  profound  morphological  alterations  in  central  visual  areas.  However,  little  is
known  about  the  response  of glial  cells  and  possible  inﬂammatory  processes  in  visual  brain  areas  result-
ing  from  eye  enucleation.  In  this  study,  immunoblotting  and  immunostaining  assays  revealed  increased
expression  of  astrocyte  and microglia  markers  in  the  rat  superior  colliculus  (SC)  between  1  and  15  days
after contralateral  enucleation.  A  transient  increase  of  neuronal  COX-2  protein  expression  was  also  foundeywords:
ye enucleation
lial cells
isual system
in the  SC.  To  evaluate  the  role  of  an anti-inﬂammatory  drug  in  attenuating  both  COX-2  and  glial  cell  acti-
vation,  the  synthetic  glucocorticoid  dexamethasone  (DEX)  was  administered  (1 mg/kg i.p.,  for  3 days)  to
enucleated rats.  Immunoblotting  data  revealed  that  DEX  treatment  signiﬁcantly  inhibited  COX-2  pro-
tein  expression.  Postlesion  immunostaining  for  astrocyte  and  microglia  markers  was  also  signiﬁcantly
reduced  by DEX  treatment.  These  ﬁndings  suggest  that  the removal  of  retinal  ganglion  cell  input  generates
in  cenOX-2 inﬂammatory  responses  
. Introduction
The visual system provides a suitable model to study the cellular
nd molecular mechanisms involved in the neuroplasticity of the
dult central nervous system. In the rat visual system, the main
rimary retinal projection areas are the superior colliculus (SC) and
he dorsal lateral geniculate nucleus (DLG). More than 90% of the
etinal ganglion cells cross at the optic chiasm and only a small
mount of the retinocollicular ﬁbers (from 5 to 3%) had been shown
o project to the ipsilateral hemisphere of the brain (Sefton et al.,
004).
The experimental manipulation of the visual system has
ttracted particularly interest because the retinal inputs to
etinorecipient areas are highly arranged topographically. The
esions are also easy to perform and completely reproducible.
nilateral loss of the retinal inputs can be induced by section-
ng the optic nerve or by eye enucleation. The morphological,
unctional and biochemical alterations speciﬁcally induced by
ye enucleation have signiﬁcantly extended our knowledge of
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mechanisms involved in the neuroplasticity events in several struc-
tures of the visual system (Smith and Bedi, 1997). The removal of
the retinal input leads to the degeneration of the corresponding
optic nerve terminals and induces a series of morphological
changes predominantly in the contralateral retinorecipient struc-
tures (Cajal, 1911; Nauta and van Straaten, 1947). However,
anatomical studies on the projection targets of the ﬁrst-order (SC
and DLG) and second-order (e.g. visual cortices) centers revealed
that both contralateral and ipsilateral hemispheres are deeply
affected by this intervention (Wree and Schleicher, 1988).
Several studies have suggested that ocular enucleation results in
profound alterations in the SC. In the rat, it has been demonstrated
that eye enucleation causes selective decrease in the immunore-
activity for glutamate receptors into the contralateral SC (Kim
and Jeon, 1999; Ortega et al., 1995). The volume of stratum gri-
seum superﬁciale (SGS), one of the superﬁcial layers of the SC,
was reduced by about 40% on the side contralateral to the enu-
cleated eye, in the same way as the numerical density of neurons
(Smith and Bedi, 1997). Using a microarray enzymatic assay to
detect amino acid content, it was demonstrated that the gluta-
mate content exhibited a signiﬁcant reduction into the SC after
deafferentation, whereas neither GABA nor aspartate content was
affected by that lesion (Sakurai and Okada, 1992). It has been also
demonstrated, by means of ligand binding quantitative autoradio-
graphy, that unilateral enucleation induces a selective reduction
in the serotonin receptor binding activity in the deprived SC and
DLG. A signiﬁcant reduction of the GABA receptor binding was
only observed into DLG and visual cortex (Chalmers and McCulloch,
1991).
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Although many studies have described mechanisms of neuronal
lasticity and structural remodeling induced by ocular enucleation,
ery little is known about possible inﬂammatory responses induced
y this procedure into retinorecipient structures. However, such
echanisms are relevant, considering that inﬂammatory responses
re likely to inﬂuence the repair process that occurs after neu-
al lesions. We  have previously demonstrated that the removal of
etinal ganglion cell input leads to a transient nuclear-factor B
NF-B) activation into SC, a transcription factor widely accepted
o be involved in the pathophysiology of inﬂammatory diseases.
F-B activation was effectively blocked by the treatment with
examethasone (DEX). Therefore, the experiments described here
ere designed to directly test the hypothesis that there is a sig-
iﬁcant inﬂammatory component in the SC after unilateral eye
nucleation in adult rats. The spatio-temporal protein expression
f cyclooxygenase-2 (COX-2) and of astrocyte and microglia mark-
rs was evaluated in the SC after retinal removal. In addition,
he effect of the synthetic glucocorticoid dexamethasone (DEX) in
ttenuating both COX-2 expression and glial cell activation was  also
etermined.
. Materials and methods
.1. Animals
Nine week-old male Wistar rats, weighing between 180 and
00 g, were used throughout this study. Animals were singly
oused and maintained on a 12:12 h light/dark cycle. All procedures
ere approved by the Institutional Animal Care Committee of the
nstitute of Biomedical Sciences, University of São Paulo (protocol
umber 017/2007).
.2. Unilateral enucleation
The animals were anesthetized with ketamine hydrochloride
5 mg/100 g of body weight, i.m.) and xylazine (1 mg/100 g of body
eight, i.m.). Lidocaine was applied around the eye before and after
nucleation. A piece of absorbable gelatin (Gelfoam, Upjohn, Kala-
azoo, MO,  USA) was placed inside the orbit for better healing.
he eyelids were sutured and the animals were returned to the
nimal facility. Animals used for immunoblotting (n = 35) were sac-
iﬁced after different survival times, namely 1 h and 1, 7, 10, 15, and
0 days after unilateral enucleation. An additional group of rats
n = 25) were unilaterally enucleated, allowed to survive for 7 days,
nd treated with DEX; their brains were used to evaluate COX-2
rotein expression by means of immunoblotting assays and to ana-
yze astrocyte (glial ﬁbrillary acidic protein – GFAP) and microglia
OX42) immunostaining. Five other rats were unilaterally enucle-
ted and their brains were used for COX-2 immunoﬂuorescence
ssays. Intact animals were used as control groups.
.3. Dexamethasone treatment
Eye-enucleated animals received daily injections of DEX
1 mg/kg i.p., for 3 days), a synthetic glucocorticoid with anti-
nﬂammatory properties (Barel et al., 2010). DEX was  dissolved
n saline and thus the control groups received saline injections.
even days after the lesion the brains were processed for both
mmunohistochemistry for GFAP and OX42 and for immunoblot-
ing assays..4. Western blotting
In the various time-points after ocular enucleation, animals
ere decapitated and the SC quickly collected, frozen in liquidResearch Bulletin 101 (2014) 1– 6
nitrogen and stored at −70 ◦C until use. The tissue was then homog-
enized at 4 ◦C in extraction buffer (Tris, pH 7.4, 100 mM;  EDTA
10 mM;  PMSF 2 mM;  aprotinin 0.01 mg/ml). The homogenates were
centrifuged at 12,000 rpm at 4 ◦C for 20 min, and the protein con-
centration of the supernatant was determined using a protein
assay kit (Bio-Rad, San Diego, CA, USA). The material was stored
in sample buffer (Tris/HCl 125 mM,  pH 6.8; 2.5% (p/v) SDS; 2.5%
2-mercaptoethanol, 4 mM EDTA and 0.05% bromophenol blue) at
−70 ◦C until immunoblotting assay. Fifty to 75 g of total protein
in Laemmli buffer were boiled for 5 min  and separated by 6.5%
acrylamide SDS gels (Bio-Rad, San Diego, CA, USA) at 25 mA and
electrophoretically transferred to nitrocellulose membranes (Mil-
lipore, Billerica, MA,  USA) at 15 V for 45 min  using a Trans-Blot cell
system (Bio-Rad, San Diego, CA, USA). The membranes were then
blocked for 2 h at room temperature with phosphate buffered saline
(PBS) containing 0.05% Tween-20 (TTBS) and 5% non-fat milk, and
incubated overnight at 4 ◦C with mouse anti-rat OX42 (CD11b/c,
Biosciences, CA, USA), mouse anti-rat GFAP (Immunon, Pittsburgh,
PA, USA) and with goat anti-rat COX-2 (Abcam, Cambridge, UK) at a
concentration of 1:1000. The membranes were then incubated for
2 h with anti-mouse-HRP IgG for OX42 and GFAP (Santa Cruz, CA,
USA), and anti-goat-HRP for COX-2 (Santa Cruz, CA, USA), diluted
1:1000 in TTBS with 1% non-fat milk. The probed proteins were
developed by using a chemiluminescent kit (ECL, Amersham Bio-
sciences, EUA). To detect multiple signals using a single membrane,
the membrane was incubated for 30 min  at room temperature with
stripping buffer. An anti--actin antibody (Sigma, St Louis, MO)  was
used to quantify -actin as a loading control. The bound antibod-
ies were visualized using radiographic ﬁlms. The quantiﬁcation of
band intensity was performed with Image J (National Institutes of
Health/USA).
2.5. Immunoperoxidase
Seven days after ocular enucleation, rats were deeply anes-
thetized with ketamine hydrochloride and xylazine and subjected
to transcardiac perfusion, with a buffered saline solution, followed
by a ﬁxative solution composed of 4% paraformaldehyde (PFA)
dissolved in 0.1 M phosphate buffer (PB, pH 7.4). The brain was
collected, post-ﬁxed in PFA for 4 h, and transferred to a 30%
sucrose solution in PB to ensure cryoprotection, which lasted
for 48 h. The brain sections (30 m) were obtained on a sliding
microtome adapted for cryosectioning. The sections were incu-
bated free-ﬂoating for 12–16 h with the same primary antibodies
used for immunoblotting anti-GFAP and anti-OX42, both diluted
1:1000 in 0.3% of Triton X-100, containing 0.05% normal donkey
serum. Following 3 washes of 10 min  each with PB, sections
were incubated for 2 h with the biotinylated secondary antibody
(donkey anti-mouse IgG, Jackson ImmunoResearch, West Grove,
PA, USA, 1:200), then with the avidin–biotin complex (1:100;
ABC Elite kit, Vector Labs, Burlingame, CA, USA). After washing,
the sections were reacted with 0.05% 3,3-diaminobenzidine and
0.01% hydrogen peroxide in PB. Intensiﬁcation was conducted
with 0.05% osmium tetroxide in water. The sections were mounted
on gelatinized slides, dehydrated, cleared and coverslipped. Con-
trols for immunostaining included the omission of the primary
antibody and its substitution for normal mouse serum, which
completely eliminated staining. The material was analyzed on a
light microscope and digital images were collected. Quantitative
image analysis was  performed using ImageJ (National Institutes
of Health/USA). GFAP and OX42 immunostaining was evaluated
in terms of optical density within 0.4 mm2 areas of the superﬁcial,
visual portion of the SC. The mean optical density of SC labeled
areas was  compared with the mean density of neighboring,
non-labeled areas in the same sections, to obtain a labeling index
reﬂecting the mean signal-to-noise ratio. The resulting indexes
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Fig. 1. Effects of eye enucleation on GFAP protein levels in the SC. In (A), mean ratio
of  GFAP densitometric data in relation to beta-actin after different survival periods
post-lesion. Signiﬁcance compared to control at *p < 0.001 and **p  < 0.05. In (B), digi-M.S. Hernandes, L.R.G. Britto / 
or the control and deafferented groups were then compared and
ubjected to statistical analysis using Graphpad Prism (3.02).
.6. Immunoﬂuorescence
For co-localization studies, immunoﬂuorescence tissue prepa-
ation was performed in the same conditions as in the
mmunoperoxidase assays, described above. Brieﬂy, the brain sec-
ions were incubated free-ﬂoating for 12–16 h with the following
rimary antibodies: mouse anti-rat GFAP, mouse anti-rat OX42,
ouse anti-rat NeuN (Chemicon, Billerica, MA,  USA) and goat anti-
at COX-2 diluted 1:500 in 0.3% of Triton X-100. Anti-goat FITC
onjugated (1:250; Abcam, Cambridge, UK) and anti-mouse TRITC
onjugated (1:250; Abcam, Cambridge, UK) secondary antibodies
ere used. The sections were mounted on gelatinized slides and
overslipped. Negative controls were performed by the omission
f primary antibody or secondary antibody. The material was ana-
yzed on a confocal microscope and digital images were collected.
.7. Statistical analysis
Values are expressed as means ± S.E.M. Statistical comparisons
ere performed by one-way ANOVA, followed by Tukey’s multi-
le comparison test. Values of p ≤ 0.05 were considered signiﬁcant.
ata from the contralateral side of the brain to the removed eye
as always compared to data obtained from intact animals. The
umber of rats (n) used in each group is referred to in the text.
. Results
.1. Immunoblotting
Immunoblotting data revealed increased GFAP, OX42 and COX-2
rotein expression after unilateral enucleation. As shown in Fig. 1A,
ensitometric analyses revealed an increase of GFAP protein levels
n SC at days 7 (ca. 551%) and 15 postlesion (ca. 240%). Simi-
ar results were also observed for OX42, for which a signiﬁcant
ncrease was observed at day 7 (ca. 205%) postlesion (Fig. 2A). For
OX-2, the increase of optical density started as early as 1 h (ca.
87%) and 1 day (ca. 258%), persisting until day 7 postlesion (ca.
18%). This effect appeared to decrease progressively thereafter
Fig. 3A). Immunoblotting data also revealed that DEX treatment
igniﬁcantly inhibited COX-2 protein expression in SC 7 days after
nilateral enucleation (Fig. 3B).
.2. Immunoperoxidase
In agreement to our immunoblotting data, immunostaining for
FAP was markedly increased (ca. 165%) in the SC at 7 days postle-
ion (Fig. 1B and C). A consistent increase of OX42 immunostaining
ca. 130%) was also found in the superﬁcial layers of the SC 7 days
fter eye enucleation, when compared to control animals (Fig. 2B
nd C). The treatment with DEX signiﬁcantly decreased both GFAP
by about 162%) and OX42 immunostaining (by about 80%), as
epicted in Figs. 1 and 2, respectively.
.3. Immunoﬂuorescence
The observation that COX-2 increased protein expression was
nduced by ocular enucleation in the SC led us to test whether
his protein is expressed in neurons, astrocytes or microglial cells.
onsistent with the immunoblotting results, a signiﬁcant increase
f COX-2 expression was observed in the SC 7 days after ocular
nucleation, in comparison to the control group (data not shown).
OX-2 displayed coexpression with NeuN in the SC, indicating
euron-speciﬁc expression of COX-2 (Fig. 4). Neither astrocytes nortal  images of GFAP immunoreactivity in the control, control + DEX, deafferented and
deafferented + DEX conditions 7 days post-lesion. In (C), GFAP immunoreactivity
optical density data. *p < 0.001 (control vs deafferented) and **p < 0.001 (deaffer-
ented vs deafferented + DEX). DEX: dexamethasone.
microglia expressed COX-2, as veriﬁed by co-immunostaining of
COX-2 with GFAP (astrocytes) or OX42 (microglia) (Fig. 4).
4. Discussion
In the present study we  hypothesized that unilateral eye enucle-
ation elicits inﬂammatory-mediated responses in a retinorecipient
structure. Our principal ﬁndings demonstrate that (1) Deafferenta-
tion of the visual system resulted in increased transient glial
cell activation and COX-2 protein expression in SC; (2) The sys-
temic administration of dexamethasone, a synthetic glucocorticoid,
attenuated both glial cell activation and COX-2 protein expression;
(3) COX-2 was found to be expressed only in neurons.
In rodents, visual information from the retina is predominantly
sent to the SC through the optic nerve constituted by retinal
ganglion cells (RGCs) axons (Sefton et al., 2004). The degeneration
4 M.S. Hernandes, L.R.G. Britto / Brain Research Bulletin 101 (2014) 1– 6
Fig. 2. Effects of ocular enucleation on OX42 protein levels in the SC. In (A), mean
ratio of OX42 densitometric data in relation to beta-actin after different survival
periods post-lesion. Signiﬁcance compared to control at **p < 0.05. In (B), digital
images of OX42 immunoreactivity in the control, control + DEX, deafferented and
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Fig. 3. Effects of ocular enucleation on COX-2 protein levels in the SC. In (A), mean
ratio of COX-2 densitometric data in relation to beta-actin. Signiﬁcance compared to
control at *p < 0.001 and **p < 0.05. In (B), effect of DEX treatment on COX-2 proteineafferented + DEX conditions 7 days post-lesion. In (C), OX42 immunoreactivity
ptical density data. *p < 0.001 (control vs deafferented) and **p < 0.05 (deafferented
s deafferented + DEX). DEX: dexamethasone.
f RGC results in irreversible blindness found in several major
ision-threatening diseases such as glaucoma and diabetic
etinopathy (Yokota et al., 2011). Moreover, several clinical and
xperimental studies have demonstrated that RGC degeneration
n glaucoma shares some common features with axonopathies of
everal pathologic processes such as Alzheimer and Parkinson’s
iseases, although the mechanisms driving these phenomena are
ar from being understood (McKinnon, 2003; Guo et al., 2007).
revious studies in animal models of glaucoma have demonstrated
hat the distal transport depletion in the SC is an early manifesta-
ion of the disease onset. Since then, the SC has attracted increased
ttention in experimental glaucoma research as it may  represent a
romising target to reduce glaucomatous neurodegenerationexpression in the SC from animals allowed to survive for 7 days postlesion. *p < 0.05
(control vs deafferented) and *p < 0.05 (deafferented vs deafferented + DEX). DEX:
dexamethasone.
(Crish et al., 2010). Thus, the investigation of speciﬁc inﬂamma-
tory pathways elicited by RGC degeneration in a retinorecipient
structure such as SC may  represent a new direction in the pursuit
of effective therapies for glaucoma and other neurodegenerative
conditions.
The initial experiments performed in this study demonstrated
that deafferentation resulted in increased glial cell activation in SC.
These results are in accordance with earlier studies in which it was
demonstrated that unilateral optic nerve lesions change the glial
cell population in the SC (Rao and Lund, 1989; Schmidt-Kastner
et al., 1993). A response of the glial cell population was  also reported
in the adult rat hippocampus deafferented by unilateral lesion of
the entorhinal cortex (Gall et al., 1979). It has been suggested
that increased glial activation may  be a consequence of the cen-
tral inﬂammatory tissue reaction induced by the deafferentation of
the brainstem vestibular nuclei (Campos-Torres et al., 1999). In line
with this, we therefore suggest that the reactive gliosis observed in
the SC after eye enucleation may  also represent an inﬂammatory
response induced by the lesion.
Several in vitro and in vivo experimental models of brain
inﬂammation have demonstrated that not only microglia, but also
astrocytes, blood inﬂammatory cells, and even neurons partici-
pate in the modulation of the inﬂammatory response. Astrocyte
activation in the nervous system is frequently associated with
brain inﬂammation (Campos-Torres et al., 1999). Astrocytes pro-
duce several anti-inﬂammatory factors (Kim et al., 2010) and
chemokines that recruit monocytes (Kim et al., 2011). In addi-
tion, astrocytes induce the expression of antioxidant enzymes such
as heme oxygenase-1, which are able to inhibit microglial activa-
tion (Min  et al., 2006). Morphologically, reactive astrocytes display
hypertrophy of their cellular processes, elongation of cytoplasmic
M.S. Hernandes, L.R.G. Britto / Brain 
Fig. 4. Effects of ocular enucleation on COX-2 expression in the SC. Representative
confocal microscopy images illustrating COX-2 immunostaining in the SC of control
(left column) and deafferented (right column) mice 7 days after the lesion. Immuno-
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ctaining was carried out using antibodies for COX-2 (shown in green) together with
euN (top), GFAP (center) and OX42 (bottom). Microglia, astrocyte, and neuronal
arkers are shown in red. COX-2 positive cells are neurons.
rocesses, hyperplasia and an increased GFAP immunostaining.
FAP is an intermediate ﬁlament protein speciﬁcally produced by
strocytes, and its increased expression is considered to be a marker
f reactive astrocytes (Malhotra et al., 1990).
Microglial cells, in turn, represent the resident immune cells
f the brain, and their activation seems to coordinate the inﬂam-
atory response in the nervous system (Kato et al., 1996;
ynch, 2009). Activation of microglia is linked to the secre-
ion of a number of inﬂammatory mediators including cytokines,
hemokines, eicosanoids, reactive oxygen species (ROS) and nitric
xide (Gehrmann et al., 1995). Similarly to astrocytes, microglial
ells also change their morphology and function in response to
eural lesions. Activated microglia show an increased cell body
ize, a thickening of proximal processes and a decrease in the ram-
ﬁcation of distal branches (Raivich et al., 1999). Corroborating
ur results, three days after the transection of the facial nerve, an
ncreased immunoreactivity for a microglial marker was observed
nto the facial motor nucleus (Raivich et al., 1999). It has been
lso demonstrated that the pro and anti-inﬂammatory cytokines
roduced by activated microglial cells could promote the survival
f deafferented vestibular neurons, contributing to the vestibular
ompensation process (Liberge et al., 2010).Besides astrocyte and microglial cell involvement in the inﬂam-
atory response, two other aspects involving its activation deserve
onsideration. First, it has been demonstrated that reactive glial
ells act by supporting several aspects of regeneration suchResearch Bulletin 101 (2014) 1– 6 5
as collateral sprouting and synaptic recovery, and maintaining
homeostasis of extracellular ﬂuid by taking up glutamate (Pekny
and Nilsson, 2005). Since high levels of glutamate are present in
the retinocollicular synaptic terminals (Li et al., 1996) and the
deafferentation may  cause a massive release of this neurotrans-
mitter shortly after the lesion (Choi, 1988; Dye and Karten, 1996),
the astrocyte and microglial activation may  represent a protective
mechanism against glutamate excitotoxicity and, consequently,
against the deafferentation trauma. Second, both astrocytes and
microglial cells have been described to be phagocytically active
both in vitro and in vivo conditions (Ito et al., 2007; Kalmar et al.,
2001). Therefore, it has been speculated that increased expres-
sion of astrocytes and microglia after deafferentation may  reﬂect
their function as phagocytotic cells to remove the debris gener-
ated by the degeneration of the retinocollicular ﬁbers and axon
terminals.
Having in mind that eye enucleation may  induce an inﬂamma-
tory response into the SC, we further investigated whether glial
cell activation could be inhibited by the treatment with an anti-
inﬂammatory. DEX is a synthetic glucocorticoid able to inhibit glial
activation induced by different inﬂammatory stimuli (Felts et al.,
2005; Nadeau and Rivest, 2003; Pan et al., 2001). The results showed
that DEX was able to signiﬁcantly decrease both microglia and
astrocytic activation into the SC. Similar results have also been
demonstrated in different experimental models, such as in cultured
microglia (Ganter et al., 1992), in the suprachiasmatic nucleus of
adrenalectomized rats (Maurel et al., 2000), and after the insertion
of neural prosthetic devices in the rat neocortex (Spataro et al.,
2005).
COX-2 is one of the most important components of the
inﬂammatory response (Nogawa et al., 1997). Neuroinﬂammatory
processes involving increased expression of COX-2 have been asso-
ciated with several neurodegenerative diseases, such as Parkinson’s
disease, Alzheimer’s disease and amyotrophic lateral sclerosis
(Minghetti, 2004). In the present study, upregulation of COX-2 was
observed as early as 1 h after the lesion, and it was  found to be
intense for one to seven days and then declined until day 30. We
also demonstrated that COX-2 was  found only in neurons. Similarly,
COX-2 was found to be co-localized predominantly in the spinal
dorsal horn neurons after spinal nerve ligation (Lau et al., 2013). The
beneﬁcial effect of the anti-inﬂammatory DEX on decreasing COX-
2 protein expression suggests that COX-2 plays a proinﬂammatory
role in deafferentation-induced neuroinﬂammation. Similar results
have also been recently described following partial hepatectomy.
The treatment with a COX-2 inhibitor decreased the hippocampal
inﬂammation induced by that procedure (Peng et al., 2013).
In summary, the ﬁndings of the present study reveal that eye
enucleation induces glial cell activation in the rat SC. Addition-
ally, the lesion also leads to COX-2 upregulation in neurons, and
both glial cell activation and COX-2 upregulation can be inhibited
by treatment with an anti-inﬂammatory. Our results suggest that
the removal of retinal ganglion cell input generates inﬂammatory
responses in central retinorecipient structures, which may play
an important role in neuronal degeneration and deafferentation-
related neuroplasticity of the rat visual system.
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